NovaBridge Biosciences (NBP) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2023 | 894.81M CNY | -23.1% |
| 2022 | 1.16B CNY | +11.7% |
| 2021 | 1.04B CNY | +47.4% |
| 2020 | 706.65M CNY | +5.8% |
| 2019 | 668.09M CNY | +60.7% |
| 2018 | 415.68M CNY | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2023 | 894.81M CNY | -23.1% |
| 2022 | 1.16B CNY | +11.7% |
| 2021 | 1.04B CNY | +47.4% |
| 2020 | 706.65M CNY | +5.8% |
| 2019 | 668.09M CNY | +60.7% |
| 2018 | 415.68M CNY | — |